Furthermore, using diagnosticplatforms, including pilot serum and fecal antigen capture enzyme-linkedimmunosorbent assay (ELISA) tests, the diagnostic capacities of cathepsinL zymogens were assessed and validated, offering promising efficacyas markers of infection and for monitoring treatment efficacy. This evidence concerns the gene CTSL and infection.